Sperm DNA integrity in cancer patients before and after cytotoxic treatment.
@article{Smit2010SpermDI,
title={Sperm DNA integrity in cancer patients before and after cytotoxic treatment.},
author={Marij Smit and Niels J. van Casteren and Mark F. Wildhagen and J C Romijn and Gert R. Dohle},
journal={Human reproduction},
year={2010},
volume={25 8},
pages={
1877-83
}
}BACKGROUND
We assessed sperm DNA fragmentation index (DFI) in cancer patients before and after treatment to evaluate if sperm DNA integrity is compromised by cancer itself or its treatment.
METHODS
In a prospective study, DFI was assessed in 127 patients diagnosed with testicular germ cell tumours (TGCT), Hodgkin's lymphoma (HL), non-Hodgkin's lymphoma (NHL) and various malignancies. The severity of cancer and tumour markers at diagnosis was recorded. Follow-up DFI after treatment was…
63 Citations
Testicular cancer and sperm DNA damage: short‐ and long‐term effects of antineoplastic treatment
- Medicine, BiologyAndrology
- 2015
It is shown that the chromatin profile may be affected in the months immediately following the end of the treatment, improving after 12–24 months, indicating that post‐treatment DNA damage is influenced both by the type and intensity of the therapy and by the pathological and clinical stage of the disease.
Impact of lymphoma treatments on spermatogenesis and sperm deoxyribonucleic acid: a multicenter prospective study from the CECOS network.
- MedicineFertility and sterility
- 2014
Sperm chromatin structure components are differentially repaired in cancer survivors.
- Biology, MedicineJournal of andrology
- 2012
Sperm monobromobimane and chromomycin A3 labeling in cancer patients were similar to those from community volunteers by 18 months after treatment, and sperm DNA damage and low DNA compaction remained up to 24 months posttreatment.
Fatherhood and Sperm DNA Damage in Testicular Cancer Patients
- Medicine, BiologyFront. Endocrinol.
- 2018
Studies found a high level of sperm DNA damage in TC patients in comparison with healthy, fertile controls, but no significant difference between these patients and infertile patients, and studies investigating the magnitude of this damage could have a considerable translational importance in the management of cancer patients.
Evaluation of sperm DNA quality in men presenting with testicular cancer and lymphoma using alkaline and neutral Comet assays
- BiologyAndrology
- 2018
It is shown that sperm DNA testing using alkaline and neutral Comet assays is more sensitive than semen analysis in detecting impaired sperm quality in men presenting with cancer and may provide a useful adjunct when considering storage prior to cancer investigations and assisted reproductive techniques (ART)‐based treatment.
Sperm DNA Damage in Cancer Patients.
- Biology, MedicineAdvances in experimental medicine and biology
- 2019
Developing new fertility preservation strategies is essential as sperm cryopreservation before treatment is currently the only option but does not apply for prepubertal/young postpubertal patients.
Sperm DNA fragmentation in cryopreserved samples from subjects with different cancers.
- Biology, MedicineReproduction, fertility, and development
- 2017
The results of the present study suggest that higher SDF levels may contribute to the lower IVF success of cryopreserved spermatozoa from cancer patients and that evaluation of SDF could complement genetic counselling as part of the routine management of cancer patients who seek fertility preservation.
Impact of chemotherapy and radiotherapy for testicular germ cell tumors on spermatogenesis and sperm DNA: a multicenter prospective study from the CECOS network.
- MedicineFertility and sterility
- 2013
Mechanisms and clinical correlates of sperm DNA damage.
- BiologyAsian journal of andrology
- 2012
It is difficult to decide whether SDF testing should be carried out in fertility assessment and ART, and there is an urgent need for the standardisation of the methods and for additional clinical studies on the impact of SDF on ART outcomes.
References
SHOWING 1-10 OF 33 REFERENCES
Sperm DNA integrity in testicular cancer patients.
- MedicineHuman reproduction
- 2006
Iradiation increases sperm DNA damage 1-2 years after treatment, and 38% of irradiated patients with normozoospermia had high (>27%) DNA damage, which may affect the sperm-fertilizing ability.
Sperm DNA integrity in cancer patients: the effect of disease and treatment.
- Medicine, BiologyInternational journal of andrology
- 2009
Sperm DNA integrity was investigated in cryopreserved semen from 121 cancer patients, the predominating diagnoses were germ cell cancer and Hodgkin's lymphoma, and no increase was seen in DFI comparing pre- and post-treatment semen, regardless of treatment modality.
Sperm integrity pre- and post-chemotherapy in men with testicular germ cell cancer.
- Medicine, BiologyHuman reproduction
- 2006
Despite the improvement in sperm chromatin packaging after chemotherapy, an abnormally high percentage of DNA-damaged sperm was found in these samples.
Characterization of sperm chromatin quality in testicular cancer and Hodgkin's lymphoma patients prior to chemotherapy.
- Medicine, BiologyHuman reproduction
- 2008
A combination of the comet assay with tests that evaluate sperm DNA compaction, such as flow cytometry-based CMA3 and mBBr assays, is a reliable strategy to characterize sperm chromatin quality in cancer patients at the time of sperm banking.
Semen quality and spermatozoal DNA integrity in survivors of childhood cancer: a case-control study
- Medicine, BiologyThe Lancet
- 2002
Sperm nuclear apoptotic DNA fragmentation in men with testicular cancer.
- MedicineFertility and sterility
- 2008
An evaluation of chromatin condensation and DNA integrity in the spermatozoa of men with cancer before and after therapy
- Biology, MedicineAndrologia
- 2005
In men with cancer, the percentage of spermatozoa with highly condensed DNA was less than that of controls and DNA integrity when assessed using the comet assay was also reduced by cancer.
Sperm DNA damage and cancer treatment.
- BiologyInternational journal of andrology
- 2002
In a man treated with chemotherapy for cancer there was increased and persistent DNA damage in sperm, consistent with the generation of human genetic diseases after conception with sperm carrying high loads of DNA damage.
Increased aneuploidy in spermatozoa from testicular tumour patients after chemotherapy with cisplatin, etoposide and bleomycin.
- Medicine, BiologyHuman reproduction
- 2001
Spermatozoa aneuploidy occurring during the spermatogenesis recovery period might be a possible side effect of the PEB regimen, and practitioners should be advised to provide counselling about the need for an appropriate duration of contraception.
Gonadal dysfunction in male cancer patients before cytotoxic treatment.
- Medicine, BiologyInternational journal of andrology
- 2010
Although pre-treatment raised tumour markers were associated with a decrease in inhibin B and increased follicle stimulating hormone, both predictive for low semen quality; no direct linear association could be found between raised beta-HCG, alfa-fetoprotein and semen quality.



